Haughey and Campanelli: pair of Par promotions
This article was originally published in Scrip
Par Pharmaceutical, a US-based speciality pharmaceutical company, has appointed Thomas Haughey president and Paul Campanelli chief operating officer, both reporting to Patrick LePore, Par's CEO and chair. Mr Haughey has served as Par's chief administrative officer since 2008, and executive vice-president since 2006. Mr Campanelli will retain his current title of president of Par's generics division in addition to his new role, and will also assume responsibility for Strativa Pharmaceuticals, a branded division of the company.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.